PDE-5 inhibitors such as tadalafil may cause transient increases in IOP, necessitating thorough ocular history and screening.

Functional vision loss can convince patients they’re suddenly unable to see, but a case demonstrates how a fogging vision ...

Case report from SECO 2026 shows how a rare blood disorder can be an atypical cause of nonarteritic anterior ischemic optic neuropathy.

Dry eye disease is linked to poor sleep quality, with shared inflammatory pathways contributing to a bidirectional relationship in patients.

Patients with Demodex blepharitis show significantly higher rates of microbial co-infestation than healthy controls.

Fae B. Kayarian, MD, provides a brief history of the innovations in retinal screenings that have brought us to the precipice ...

A pair of phase 3 clinical trial results show favorable safety and IOP-lowering effects in glaucoma and ocular hypertension.

Perfluorohexyloctane ophthalmic solution treatment can significantly reduce dry eye signs and symptoms in cataract surgery patients.

Researchers conducted a propensity-matched cohort study to assess the neuroprotective effects of GLP-1RA therapy in type 2 diabetes.

Clinicians report high satisfaction with lifitegrast for improving ocular signs and symptoms of dry eye disease.

Low-dose pilocarpine can improve CDVA without affecting accommodative stimuli responses of the ciliary muscle.